Literature DB >> 20110144

Culture-negative peritonitis in peritoneal dialysis patients in Australia: predictors, treatment, and outcomes in 435 cases.

Magid Fahim1, Carmel M Hawley, Stephen P McDonald, Fiona G Brown, Johan B Rosman, Kathryn J Wiggins, Kym M Bannister, David W Johnson.   

Abstract

BACKGROUND: Reports of culture-negative peritoneal dialysis (PD)-associated peritonitis have been sparse, conflicting, and limited to small single-center studies. The aim of this investigation is to examine the frequency, predictors, treatment, and outcomes of culture-negative PD-associated peritonitis. STUDY
DESIGN: Observational cohort study using Australia and New Zealand Dialysis and Transplant Registry (ANZDATA) data. SETTING & PARTICIPANTS: All Australian PD patients between October 1, 2003, and December 31, 2006. PREDICTORS: Demographic, clinical, and facility variables. OUTCOMES & MEASUREMENTS: Culture-negative PD-associated peritonitis occurrence, relapse, hospitalization, catheter removal, hemodialysis transfer, and death.
RESULTS: Of 4,675 patients who received PD in Australia during the study period, 435 episodes of culture-negative peritonitis occurred in 361 individuals. Culture-negative peritonitis was not associated with demographic or clinical variables. A history of previous antibiotic treatment for peritonitis was more common with culture-negative than culture-positive peritonitis (42% vs 35%; P = 0.01). Compared with culture-positive peritonitis, culture-negative peritonitis was significantly more likely to be cured using antibiotics alone (77% vs 66%; P < 0.001) and less likely to be complicated by hospitalization (60% vs 71%; P < 0.001), catheter removal (12% vs 23%; P < 0.001), permanent hemodialysis therapy transfer (10% vs 19%; P < 0.001), or death (1% vs 2.5%; P = 0.04). Relapse rates were similar between the 2 groups. Patients with relapsed culture-negative peritonitis were more likely to have their catheters removed (29% vs 10% [P < 0.001]; OR, 3.83; 95% CI, 2.00-7.32). Administration of vancomycin or cephalosporin in the initial empiric antibiotic regimen and the timing of catheter removal were not significantly associated with clinical outcomes. LIMITATIONS: Limited covariate adjustment. Residual confounding and coding bias could not be excluded.
CONCLUSIONS: Culture-negative peritonitis is a common complication with a relatively benign outcome. A history of previous antibiotic treatment is a significant risk factor for this condition. Copyright 2010 National Kidney Foundation, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20110144     DOI: 10.1053/j.ajkd.2009.11.015

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  31 in total

1.  Risk factors and outcome of contamination in patients on peritoneal dialysis--a single-center experience of 15 years.

Authors:  Desmond Y H Yap; Wai Ling Chu; Flora Ng; Terence Pok Siu Yip; Sing Leung Lui; Wai Kei Lo
Journal:  Perit Dial Int       Date:  2012-06-01       Impact factor: 1.756

2.  Weekend compared with weekday presentations of peritoneal dialysis-associated peritonitis.

Authors:  David W Johnson; Philip Clayton; Yeoungjee Cho; Sunil V Badve; Carmel M Hawley; Stephen McDonald; Neil Boudville; Kathryn J Wiggins; Kym Bannister; Fiona Brown
Journal:  Perit Dial Int       Date:  2012-02-01       Impact factor: 1.756

3.  Peritonitis and exit site infections in First Nations patients on peritoneal dialysis.

Authors:  Ainslie Hildebrand; Paul Komenda; Lisa Miller; Claudio Rigatto; Mauro Verrelli; Amy R Sood; Chris Sathianathan; Martina Reslerova; Loretta Eng; Amanda Eng; Manish M Sood
Journal:  Clin J Am Soc Nephrol       Date:  2010-08-19       Impact factor: 8.237

4.  Is female sex really a risk factor for infectious death in peritoneal dialysis?

Authors:  David W Johnson; Yeoungjee Cho; Rajnish Mehrotra
Journal:  Perit Dial Int       Date:  2013 Sep-Oct       Impact factor: 1.756

5.  Improvement in culture-negative peritoneal dialysis-related peritonitis: a single center's experience.

Authors:  Ismail Kocyigit; Aydin Unal; Derya Karademir; Sami Bahcebasi; Murat H Sipahioglu; Bulent Tokgoz; Oktay Oymak; Cengiz Utas
Journal:  Perit Dial Int       Date:  2012 Jul-Aug       Impact factor: 1.756

6.  Recent peritonitis associates with mortality among patients treated with peritoneal dialysis.

Authors:  Neil Boudville; Anna Kemp; Philip Clayton; Wai Lim; Sunil V Badve; Carmel M Hawley; Stephen P McDonald; Kathryn J Wiggins; Kym M Bannister; Fiona G Brown; David W Johnson
Journal:  J Am Soc Nephrol       Date:  2012-05-24       Impact factor: 10.121

Review 7.  The Current State of Peritoneal Dialysis.

Authors:  Rajnish Mehrotra; Olivier Devuyst; Simon J Davies; David W Johnson
Journal:  J Am Soc Nephrol       Date:  2016-06-23       Impact factor: 10.121

Review 8.  Continuous Quality Improvement Initiatives to Sustainably Reduce Peritoneal Dialysis-Related Infections in Australia and New Zealand.

Authors:  Melissa Nataatmadja; Yeoungjee Cho; David W Johnson
Journal:  Perit Dial Int       Date:  2016-09-10       Impact factor: 1.756

9.  The Effect of Exit-Site Antibacterial Honey Versus Nasal Mupirocin Prophylaxis on the Microbiology and Outcomes of Peritoneal Dialysis-Associated Peritonitis and Exit-Site Infections: A Sub-Study of the Honeypot Trial.

Authors:  Lei Zhang; Sunil V Badve; Elaine M Pascoe; Elaine Beller; Alan Cass; Carolyn Clark; Janak de Zoysa; Nicole M Isbel; Steven McTaggart; Alicia T Morrish; E Geoffrey Playford; Anish Scaria; Paul Snelling; Liza A Vergara; Carmel M Hawley; David W Johnson
Journal:  Perit Dial Int       Date:  2015-07-29       Impact factor: 1.756

Review 10.  Peritoneal dialysis--current status and future challenges.

Authors:  Simon J Davies
Journal:  Nat Rev Nephrol       Date:  2013-05-21       Impact factor: 28.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.